HIGHLIGHTS
- who: Aaron S. Mansfield MD from the Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota PHMR Ltd, Berkeley Works, London, United Kingdom have published the paper: The Predictive and Prognostic Nature of Programmed Death-Ligand 1 in Malignant Pleural Mesothelioma: A Systematic Literature Review, in the Journal: (JOURNAL)
- what: Among the studies in which anti-PD-(L)1 therapies were used, 83% (five of six) did not reveal an association between survival and PD-L1 tumor expression. An SLR was designed and refined to identify studies relevant to the review objectives. A total of 26 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.